Abstract
512O Adjuvant aspirin treatment in PIK3CA mutated colon cancer patients: The phase III, prospective-randomized placebo-controlled multicenter SAKK 41/13 trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have